Status:
COMPLETED
Kidney in Coronavirus Disease 2019 Registry
Lead Sponsor:
University of Cologne
Conditions:
Corona Virus Infection
SARS-CoV 2
Eligibility:
All Genders
Brief Summary
The SARS-CoV-2 virus is a virus newly identified in January 2020. The WHO defined COVID-19 as a health emergency of international importance. The clinical manifestation of the COVID-19 disease cannot ...
Detailed Description
The SARS-CoV-2 virus is a virus newly identified in January 2020 in Wuhan, China, which belongs to the group of coronaviruses and causes COVID-19. Due to the rapid spread worldwide, high morbidity and...
Eligibility Criteria
Inclusion
- Virology evidence of SARS-CoV-2-infection
- Pathological evidence of SARS-CoV-2-infection
Exclusion
- Occurrence of ARDS (acute respiratory distress syndrome) without evidence of SARS-CoV-2 infection
- Acute kidney injury without evidence of SARS-CoV-2 infection
Key Trial Info
Start Date :
April 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 31 2025
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04797091
Start Date
April 20 2020
End Date
August 31 2025
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital of Cologne
Cologne, Germany, 50937